Energy generation in the brain to ameliorate energy deficit in migraine leads to oxidative stress as it is associated with reactive oxygen species (ROS) that may damage DNA and show a pronociceptive action in meninges mediated by transient receptor potential cation channel subfamily A member 1 (TRPA1). Recent studies show high levels of single-strand breaks (SSBs) at specific sites in the genome of postmitotic neurons and point at SSB repair (SSBR) as an important element of homeostasis of the central nervous system. DNA topoisomerase 1 (TOP1) is stabilized in the DNA damage-inducing state by neuronal stimulation, including cortical spreading depression. Impairment in poly (ADP-ribose) polymerase 1 (PARP-1) and X-ray repair cross complementing 1 (XRCC1), key SSBR proteins, may be linked with migraine by transient receptor potential melastatin 2 (TRPM2). TRPM2 may also mediate the involvement of migraine-related neuroinflammation with PARP-1 activated by oxidative stress–related SSBs. In conclusion, aberrant activity of SSBR evoked by compromised PARP-1 and XRCC1 may contribute to pathological phenomena in the migraine brain. Such aberrant SSBR results in the lack of repair or misrepair of SSBs induced by ROS or resulting from impaired TOP1. Therefore, components of SSBR may be considered a prospective druggable target in migraine.
AbugableAAMorrisJLMPalminhaNMZaksauskaiteRRaySEl-KhamisySF. 2019. DNA repair and neurological disease: from molecular understanding to the development of diagnostics and model organisms. DNA Repair (Amst)81:102669.
2.
BenemeiSFusiCTrevisanGGeppettiP. 2014. The TRPA1 channel in migraine mechanism and treatment. Br J Pharmacol171(10):2552–67.
3.
BlandiniFRinaldiLTassorelliCSancesGMottaMSamueleA, and others. 2006. Peripheral levels of BDNF and NGF in primary headaches. Cephalalgia26(2):136–42.
4.
BolayHReuterUDunnAKHuangZBoasDAMoskowitzMA. 2002. Intrinsic brain activity triggers trigeminal meningeal afferents in a migraine model. Nat Med8(2):136–42.
5.
BorkumJM. 2016. Migraine triggers and oxidative stress: a narrative review and synthesis. Headache56(1):12–35.
6.
BorkumJM. 2018a. Harnessing migraines for neural regeneration. Neural Regen Res13(4):609–15.
7.
BorkumJM. 2018b. The migraine attack as a homeostatic, neuroprotective response to brain oxidative stress: preliminary evidence for a theory. Headache58(1):118–35.
8.
BorkumJM. 2021. Brain energy deficit as a source of oxidative stress in migraine: a molecular basis for migraine susceptibility. Neurochem Res46(8):1913–32.
9.
BrasJAlonsoIBarbotCCostaMMDarwentLOrmeT, and others. 2015. Mutations in PNKP cause recessive ataxia with oculomotor apraxia type 4. Am J Hum Genet96(3):474–9.
10.
BrozPDixitVM. 2016. Inflammasomes: mechanism of assembly, regulation and signalling. Nat Rev Immunol16(7):407–20.
11.
BuelowBSongYScharenbergAM. 2008. The poly(ADP-ribose) polymerase PARP-1 is required for oxidative stress-induced TRPM2 activation in lymphocytes. J Biol Chem283(36):24571–83.
12.
CaldecottKW. 2007. Mammalian single-strand break repair: mechanisms and links with chromatin. DNA Repair (Amst)6(4):443–53.
CaldecottKW. 2020. Mammalian DNA base excision repair: dancing in the moonlight. DNA Repair (Amst)93:102921.
15.
ChiarugiA. 2002. Poly(ADP-ribose) polymerase: killer or conspirator? The ‘suicide hypothesis’ revisited. Trends Pharmacol Sci23(3):122–9.
16.
CreweMMadabhushiR. 2021. Topoisomerase-mediated DNA damage in neurological disorders. Front Aging Neurosci13:751742.
17.
CutrerFMMoyerAMAtkinsonEJWangLTianSWuY, and others. 2021. Genetic variants related to successful migraine prophylaxis with verapamil. Mol Genet Genomic Med9(6):e1680.
18.
DasBBHuangSYMuraiJRehmanIAméJCSenguptaS, and others. 2014. PARP1-TDP1 coupling for the repair of topoisomerase I-induced DNA damage. Nucleic Acids Res42(7):4435–49.
19.
DeminAAHirotaKTsudaMAdamowiczMHailstoneRBrazinaJ, and others. 2021. XRCC1 prevents toxic PARP1 trapping during DNA base excision repair. Mol Cell81(14):3018–30.e5.
20.
El-AgamySEAbdel-AzizAKEsmatAAzabSS. 2019. Chemotherapy and cognition: comprehensive review on doxorubicin-induced chemobrain. Cancer Chemother Pharmacol84(1):1–14.
21.
El-KhamisySFSaifiGMWeinfeldMJohanssonFHelledayTLupskiJR, and others. 2005. Defective DNA single-strand break repair in spinocerebellar ataxia with axonal neuropathy-1. Nature434(7029):108–13.
22.
FerreiraKSDhillonHVellyAM. 2021. The role of a potential biomarker in patients with migraine: review and new insights. Expert Rev Neurother21(7):817–31.
23.
FischerMWilleGKlienSShanibHHolleDGaulC, and others. 2012. Brain-derived neurotrophic factor in primary headaches. J Headache Pain13(6):469–75.
24.
FonfriaEMarshallICBenhamCDBoyfieldIBrownJDHillK, and others. 2004. TRPM2 channel opening in response to oxidative stress is dependent on activation of poly(ADP-ribose) polymerase. Br J Pharmacol143(1):186–92.
25.
FontehANChungRSharmaTLFisherRDPogodaJMCowanR, and others. 2011. Cerebrospinal fluid phospholipase C activity increases in migraine. Cephalalgia31(4):456–62.
26.
GeyikSAltunısıkENeyalAMTaysiS. 2016. Oxidative stress and DNA damage in patients with migraine. J Headache Pain17:10.
27.
GmeinerWHvan WaardenburgR. 2021. Targeting DNA topoisomerases: past & future. Cancer Drug Resist4:758–61.
28.
GrossECLisickiMFischerDSándorPSSchoenenJ. 2019. The metabolic face of migraine—from pathophysiology to treatment. Nat Rev Neurol15(11):627–43.
29.
HanzlikovaHGittensWKrejcikovaKZengZCaldecottKW. 2017. Overlapping roles for PARP1 and PARP2 in the recruitment of endogenous XRCC1 and PNKP into oxidized chromatin. Nucleic Acids Res45(5):2546–57.
30.
HendriksIABuch-LarsenSCProkhorovaEElsborgJDRebakAZhuK, and others. 2021. The regulatory landscape of the human HPF1- and ARH3-dependent ADP-ribosylome. Nat Commun12(1):5893.
31.
HochNCHanzlikovaHRultenSLTétreaultMKomulainenEJuL, and others. 2017. XRCC1 mutation is associated with PARP1 hyperactivation and cerebellar ataxia. Nature541(7635):87–91.
32.
HomburgSVisochekLMoranNDantzerFPrielEAsculaiE, and others. 2000. A fast signal-induced activation of poly(ADP-ribose) polymerase: a novel downstream target of phospholipase C. J Cell Biol150(2):293–307.
33.
KleebergJPetzoldGCMajorSDirnaglUDreierJP. 2004. ET-1 induces cortical spreading depression via activation of the ETA receptor/phospholipase C pathway in vivo. Am J Physiol Heart Circ Physiol286(4):H1339–46.
34.
KomulainenEBadmanJReySRultenSJuLFennellK, and others. 2021. Parp1 hyperactivity couples DNA breaks to aberrant neuronal calcium signalling and lethal seizures. EMBO Rep22(5):e51851.
35.
KoverechACicioneCLionettoLMaestriMPassarielloFSabbatiniE, and others. 2019. Migraine and cluster headache show impaired neurosteroids patterns. J Headache Pain20(1):61.
KursunOYemisciMvan den MaagdenbergAKaratasH. 2021. Migraine and neuroinflammation: the inflammasome perspective. J Headache Pain22(1):55.
39.
LiaoCBeveridgeRHudsonJJRParkerJDChiangSCRayS, and others. 2018. UCHL3 regulates topoisomerase-induced chromosomal break repair by controlling TDP1 proteostasis. Cell Rep23(11):3352–65.
40.
LiuZKrausWL. 2017. Catalytic-independent functions of PARP-1 determine Sox2 pioneer activity at intractable genomic loci. Mol Cell65(4):589–603.e9.
41.
MaluchenkoNVNilovDKPushkarevSVKotovaEYGerasimovaNSKirpichnikovMP, and others. 2021. Mechanisms of nucleosome reorganization by PARP1. Int J Mol Sci22(22):12127.
42.
MaroneIMDe LoguFNassiniRDe Carvalho GoncalvesMBenemeiSFerreiraJ, and others. 2018. TRPA1/NOX in the soma of trigeminal ganglion neurons mediates migraine-related pain of glyceryl trinitrate in mice. Brain141(8):2312–28.
43.
MatsosAJohnstonIN. 2019. Chemotherapy-induced cognitive impairments: a systematic review of the animal literature. Neurosci Biobehav Rev102:382–99.
44.
McKinnonPJ. 2017. Genome integrity and disease prevention in the nervous system. Genes Dev31(12):1180–94.
45.
MoreiraMCBarbotCTachiNKozukaNUchidaEGibsonT, and others. 2001. The gene mutated in ataxia-ocular apraxia 1 encodes the new HIT/Zn-finger protein aprataxin. Nat Genet29(2):189–93.
46.
NguyenLDEhrlichBE. 2020. Cellular mechanisms and treatments for chemobrain: insight from aging and neurodegenerative diseases. EMBO Mol Med12(6):e12075.
47.
PommierYNussenzweigATakedaSAustinC. 2022. Human topoisomerases and their roles in genome stability and organization. Nat Rev Mol Cell Biol. doi:10.1038/s41580-022-00452-3
48.
PommierYSunYHuangSNNitissJL. 2016. Roles of eukaryotic topoisomerases in transcription, replication and genomic stability. Nat Rev Mol Cell Biol17(11):703–21.
49.
Pozo-RosichPCoppolaGPascualJSchwedtTJ. 2021. How does the brain change in chronic migraine? Developing disease biomarkers. Cephalalgia41(5):613–30.
50.
ProughRAClarkBJKlingeCM. 2016. Novel mechanisms for DHEA action. J Mol Endocrinol56(3):R139–55.
51.
RamachandranR. 2018. Neurogenic inflammation and its role in migraine. Semin Immunopathol40(3):301–14.
52.
ReidDAReedPJSchlachetzkiJCMNitulescuIIChouGTsuiEC, and others. 2021. Incorporation of a nucleoside analog maps genome repair sites in postmitotic human neurons. Science372(6537):91–4.
ShatilloAKorolevaKGiniatullinaRNaumenkoNSlastnikovaAAAlievRR, and others. 2013. Cortical spreading depression induces oxidative stress in the trigeminal nociceptive system. Neuroscience253:341–9.
55.
ShenJGilmoreECMarshallCAHaddadinMReynoldsJJEyaidW, and others. 2010. Mutations in PNKP cause microcephaly, seizures and defects in DNA repair. Nat Genet42(3):245–9.
56.
SiesH. 2017. Hydrogen peroxide as a central redox signaling molecule in physiological oxidative stress: oxidative eustress. Redox Biol11:613–19.
57.
TakanoTTianGFPengWLouNLovattDHansenAJ, and others. 2007. Cortical spreading depression causes and coincides with tissue hypoxia. Nat Neurosci10(6):754–62.
58.
TanureMTGomezRSHurtadoRCTeixeiraALDominguesRB. 2010. Increased serum levels of brain-derived neurotropic factor during migraine attacks: a pilot study. J Headache Pain11(5):427–30.
59.
VisochekLSteingartRAVulih-ShultzmanIKleinRPrielEGozesI, and others. 2005. PolyADP-ribosylation is involved in neurotrophic activity. J Neurosci25(32):7420–8.
60.
WilsonDBConnollyTMBrossTEMajerusPWShermanWRTylerAN, and others. 1985. Isolation and characterization of the inositol cyclic phosphate products of polyphosphoinositide cleavage by phospholipase C: physiological effects in permeabilized platelets and Limulus photoreceptor cells. J Biol Chem260(25):13496–501.
61.
WuWHillSENathanWJPaianoJCallenEWangD, and others. 2021. Neuronal enhancers are hotspots for DNA single-strand break repair. Nature593(7859):440–44.
62.
YazğanYNazıroğluM. 2021. Involvement of TRPM2 in the neurobiology of experimental migraine: focus on oxidative stress and apoptosis. Mol Neurobiol58(11):5581–601.
63.
YoonGCK. 2018. Nonsyndromic cerebellar ataxias associated with disorders of DNA single-strand break repair. Handb Clin Neurol155:105–15.
64.
ZangiabadiSAbdul-SaterAA. 2022. Regulation of the NLRP3 inflammasome by posttranslational modifications. J Immunol208(2):286–92.
65.
ZhangXLevyDKainzVNosedaRJakubowskiMBursteinR. 2011. Activation of central trigeminovascular neurons by cortical spreading depression. Ann Neurol69(5):855–65.
66.
ZhongZZhaiYLiangSMoriYHanRSutterwalaFS, and others. 2013. TRPM2 links oxidative stress to NLRP3 inflammasome activation. Nat Commun4:1611.
